Kevin K. Brown, MD

Special Interests

---

Research Interests

Mechanisms responsible for the initiation and progression of lung fibrosis. Lung disease in patients with autoimmune disorders such as rheumatoid arthritis and scleroderma, among others.

Education

---

Education

University of Minnesota Medical School, Medical School

---

Internships

Presbyterian Hospital, Pacific Presbyterian Medical Center, Medical Internship

---

Residency

Providence Medical Center, Chief Medical Resident

Providence Medical Center, Medical Residency

---

Fellowship

Maine Medical Center, Pulmonary/ CCM Fellowship

National Jewish Health/University of Colorado Health Sciences Center, Pulmonary/CCM, Research Fellowship

---

Awards & Recognition

---

2001-2016: America's Top Doctors
2002-2016: Best Doctors in America
2004-2005: America's Top Physicians
2002: Clinician of the Year, National Jewish Health

Board Certification

---

Internal Medicine Pulmonary

Publications

---

Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med 2004 Jan 8; 350:125-33.

Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, Lynch DA, King TE, Brown KK. The Impact of Pulmonary Fibrosis on Survival in Hypersensitivity Pneumonitis. Am J Med. 2004 May 15;116(10):662-8.

Collard HR, King TE, Bucher-Bartleson B, Vourlekis JV, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42.

SurattBT, Cool CD, Serls A,Varella-Garcia M, Shpall EJ, Brown KK, Worthen GS. Human Pulmonary Microchimerism Following Hematopoietic Stem Cell Transplantation Am J Respir Crit Care Med. 2003 Aug 1;168(3):318-22.

Academic Affiliations

---

Professor, University of Colorado, Denver School of Medicine